eJIFCC Volume 14 no 2 - 2003
|Editorial - Vol 14 No 2|
|1||Pathophysiology and classification of cardiovascular diseases caused by atherosclerosis|
|2||Atherothrombosis - Pathogenesis of cardiovascular disease|
|3||Role of inflammation in the pathogenesis of acute coronary syndromes|
Luigi M. Biasucci
|4||Genetics of cardiovascular disease|
|5||The role of lipids in the development of atherosclerosis and coronary heart disease - Guidelines for diagnosis and treatment|
|6||Evaluation of risk markers for acute myocardial infarction and heart failure - Present and the future|
|7||Hypertension and coronary heart disease|
|8||Diabetes mellitus and cardiovascular disease|
|9||The role of pharmacogenetics in the management of cardiovascular disease|
|10||Natriuretic peptides in the assessment of ventricular dysfunction|
|11||Treatment of lipid disorders in cardiovascular patients|
David L. Williams
|12||Rational diagnosis of cardiovascular disease|
Mathias M. Müller, Andrea Griesmacher
|13||Recommendations on use of biochemical markers in acute coronary syndrome - IFCC proposals|
|14||Strategy of prevention of cardiovascular disease|
Gábor L. Kovács, Judit Skrapits, Lajos Nagy
Copyright © 2003 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).
All rights reserved.
Contents may not be reproduced without the prior permission of the Communications and Publications Division (CPD) of the IFCC.